The problem is no revenue stream..They tested 5 diseases and only succeeded with Bronchitis which every physician can tell by visual inspection (atleast 90% of the time).... without FDA approval it's just going to chew cash reserve and FDA is atleast 12 months away based on previous experience - Sorry previous trials were failure so don't consider that...Every thing has to go right to get there --
Ann: Dr Philip Currie Joins ResApp's Scientific Advisory Board, page-87
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 94 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)